Skip to content

Movement Sonification as an add-on to Immediate Post-event Psychotherapeutic Intervention in the Management of Acute Stress Disorder: a Feasibility and Acceptability Study

Movement Sonification as an add-on to Immediate Post-event Psychotherapeutic Intervention in the Management of Acute Stress Disorder: a Feasibility and Acceptability Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07307937
Acronym
SONICUMP
Enrollment
30
Registered
2025-12-29
Start date
2026-01-15
Completion date
2026-12-30
Last updated
2025-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Stress Disorder Symptoms

Keywords

post-traumatic stress disorder, potentially traumatic events, transforming the patient's movement into sound information

Brief summary

Natural disasters, conflicts, persecution, population displacement, often traumatic migration experiences, and terrorist attacks are all factors that currently expose a significant proportion of the world's population to potentially traumatic events (PTEs). When a person is exposed to a PTE, symptoms of acute stress disorder (ASD) may occur in the immediate aftermath of the PTB, i.e., within the month following the event. These symptoms are dominated by dissociation, which includes depersonalization, i.e., the feeling of being disconnected from one's body. Managing these symptoms can prevent the subsequent onset of post-traumatic stress disorder (PTSD), a serious illness and public health concern. The recommended treatment combines an immediate post-event psychotherapeutic intervention (IPPI) and, where appropriate, medication with anxiolytics from the antihistamine class or antipsychotics

Detailed description

In France, IPPI is carried out by the medical-psychological emergency units (CUMP) in each department. Patients are referred to these units by the CUMPs themselves when they are called out by the SAMU (emergency medical service) to the scene of mass accidents (attacks, fires, suicides in public places, etc.), or by departmental doctors and medico-legal emergency services for individual EPTs (sexual or physical assault, etc.). In Seine-Saint-Denis, the CUMP 93 receives 60 to 100 patients per year in the immediate post-traumatic phase. The purpose of IPPI is to reconnect the traumatic experience with known representations. These interventions have demonstrated effectiveness,although their preventive impact on PTSD remains limited. Movement sonification is an augmented auditory reality technique that transforms a patient's movements into sound through connected wristbands and a speaker system. By enriching bodily perception, this technique may enhance the efficacy of trauma-focused psychotherapies. This study aims to assess the acceptability and feasibility of using movement sonification in combination with IPPI for the treatment of ASD. It thereby addresses an urgent need for primary prevention of PTSD.

Interventions

DEVICEThe sonification of movement is an act studied in this research.

The sonification of movement is an act studied in this research at visit 1, visit 2 and visit 3

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 and over * Who have experienced a potentially traumatic event (PTE) other than the death of a loved one * Who have been referred to the medical-psychological emergency unit (CUMP 93) within one month of the PTE * Who are experiencing acute stress disorder (ASD) according to DSM-5 criteria * Have health insurance * Have signed a written informed consent form

Exclusion criteria

* Severe motor impairment rendering the use of sonification technology impractical * Deaf, mute, or hearing-impaired patients * Adults under guardianship or conservatorship, under judicial protection, or deprived of liberty * Suffering from chronic psychotic disorder or bipolar disorder * Central neurological disease defined by a medical report (including brain damage, cortical or subcortical atrophy, dementia, stroke, transient ischemic attack, head trauma, epilepsy, or seizure) * Presenting a proven severe risk of suicide * Substance use disorder (excluding tobacco) * Pregnant or breastfeeding women * Participation in another interventional study on ESA

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the feasibility of movement sonification in association with IPPI in the treatment of ESA.6 weeksSuccess rate, defined as an individual adherence rate of at least two sessions completed with movement sonification out of the three sessions planned.

Secondary

MeasureTime frameDescription
Agency (sense of control over the external environment)6 weeksChanges in agency assessed by the Fribourg Sense of Agency Scale from V1 to V4. A high score on the Fribourg Sense of Agency Scale (range 13 to 91) is associated with an increased perception of personal control and a stronger integration of conscious action with personal responsibility.
The overall clinical response6 weeksChange in clinical impression assessed by the Clinical Global Impression-Severity from V1 to V4. The scale ranges from 1 to 7, where a low value indicates no symptoms and 7 indicates a terminal stage disorder.
Dissociative symptoms6 weeks1\) Change in the severity of dissociative symptoms assessed by: 1a) • Clinician-Administered Dissociative States Scale from V1 to V4. A high score on the Clinician-Administered Dissociative States Scale (range 0 to 92) indicates a more severe degree of dissociative symptoms.
Symptoms associated with ESA in patients with initial symptoms of traumatic dissociation, compared to those without6 weeksComparison of changes in scale between patients according to the level of dissociation assessed by the Clinician-Administered Dissociative States Scale. A high score on the Clinician-Administered Dissociative States Scale (range 0 to 92) indicates a more severe degree of dissociative symptoms.
Evaluate the experience and acceptability of patients and caregivers (qualitative analysis).6 weeksThe evaluation of the experience and acceptability will be carried out using a semi-structured interview with the patient at Visit 4
Overall functioning6 weeksChange in overall functioning assessed by the Global Assessment of Functioning from Visit 1 to Visit 4. The Global Assessment of Functioning, scale is used to rate how serious a mental illness may be. It measures how much a person's symptoms affect their day-to-day life on a scale of 0 to 100.A high score on the Global Assessment of Functioning suggests very good or near-normal overall functioning.

Countries

France

Contacts

Primary ContactNicolas BOSC
nicolas.bosc@aphp.fr+33 1 48 95 53 74
Backup ContactSharon Soobben Project Manager
sharon.soobben@aphp.fr+33 1 48 95 74 35

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026